|Team Leader: Dr Michael Burr||Date of completion: 8/9/97|
The contents of this bulletin are likely to be valid for approximately one year, by which time significantly new research evidence may become available
(Users are advised to consult the supporting evidence for a consideration of all the implications of a recommendation)
|The Statements||The Evidence|
and smoking cessation should be a key focus of future initiatives aimed at
controlling this diseaseii.
|i. Peto R, Lopez AD, Boreham J, Thun M,
Heath C. Jr; Imperial Cancer Research Fund: World Health Organisation. Mortality from
smoking in developed countries 1950-2000. Oxford: Oxford University Press, 1994.
(Type IV evidence - statistical information);
ii. Fiel BS. Chronic obstructive pulmonary disease. Mortality and mortality reduction. Drugs 1996; 52 (Suppl. 2): 55-61
(Type IV evidence - statistical information)
|9b. Pulmonary rehabilitation is of
benefit to many patients in that it improves exercise tolerance and quality of life, at
least in the short term i.
(Health gain notation - 1 "beneficial")
caveat: A longer term study is under way ii.
|i. Lacasse Y, Wong E, Guyatt GH, King D,
Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive
pulmonary disease. Lancet 1996; 348: 1115-1119.
(Type I evidence - meta-analysis);
ii. Griffiths, Burr and Campbell. Ongoing Study. Contact Dr I Campbell (see contributors)
Health Evidence Bulletins: Wales, Duthie Library, UWCM, Cardiff CF14 4XN. e-mail: email@example.com